Trial Details
TERMINATEDBasic Information
| Clinical ID | c3775 |
|---|---|
| Identifier | NCT01545050 |
| Trial Title | Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Placebo matching with BMS-945429|BIOLOGICAL: Placebo matching with BMS-945429|BIOLOGICAL: Placebo matching with BMS-945429|BIOLOGICAL: Placebo matching with BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429|BIOLOGICAL: BMS-945429 |
Participant Information
| Sponsor | CSL Behring |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-06 |
|---|---|
| Primary Completion Date | 2013-12 |
| Completion Date | 2013-12 |